In the ATTAIN-2 trial (participants with obesity and type 2 diabetes), GI adverse event rates were somewhat higher than in ATTAIN-1: nausea 20.1-36.4% versus 8.4% with placebo, vomiting 12.8-23.1% versus 3.8%, diarrhea 21.3-27.4% versus 15.0%, and constipation 17.7-22.4% versus 7.8%
Unfortunately, these agents do not cross blood-brain barrier (BBB)
Int J Cosmet Sci
Given that co-deficiency in functional vitamin B2 is universal in autistic children this deficiency must be fixed first, and then the active forms of vitamin B12, adenosyl B12 and methyl B12 must be given either by injection or via the Transdermoil TM delivery route
Dolmans M-M, Taylor HS, Rodriguez-Wallberg KA, Blumenfeld Z, Lambertini M, Von Wolff M, Donnez J
The foundational research from his laboratory has contributed to the scientific rationale for combination peptide formulations like KLOW Blend, though specific combination studies remain to be conducted